BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/18/2022 6:01:39 AM | Browse: 383 | Download: 807
 |
Received |
|
2022-01-07 05:08 |
|
Peer-Review Started |
|
2022-01-07 05:09 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-03-10 04:15 |
|
Revised |
|
2022-03-24 22:59 |
|
Second Decision |
|
2022-08-01 03:08 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-08-05 21:38 |
|
Articles in Press |
|
2022-08-05 21:38 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-08-09 09:34 |
|
Publish the Manuscript Online |
|
2022-08-18 06:01 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Gastrointestinal manifestations, risk factors, and management in patients with post-transplant lymphoproliferative disorder: A systematic review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
William Reiche, Abubakar Tauseef, Ahmed Sabri, Mohsin Mirza, David Cantu, Peter Silberstein and Saurabh Chandan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
William Reiche, Consultant, Doctor, Doctor, Department of Medicine, CHI Creighton University Medical Center, 7500 Mercy Road, Omaha, NE 68124, United States. reichewilliam@gmail.com |
| Key Words |
Post-transplant lymphoproliferative disorder; Gastrointestinal manifestations; Reduction of immunosuppression; Risk factors; Epstein-Barr virus |
| Core Tip |
Patients with a history of solid-organ or hematopoietic stem cell transplantation are at an increased risk of developing post-transplant lymphoproliferative disorder (PTLD). The gastrointestinal (GI) tract is commonly affected as it has an abundance of B and T-cells. GI tract manifestations may be nonspecific; therefore, consideration of risk factors is crucial for identifying GI-PTLD. Like other lymphoma variants, PTLD is very aggressive making early diagnosis key to prognosis. Initial treatment is reduction of immunosuppression which is effective in more than 50% of cases; however, additional therapy including surgery and chemotherapy may also be required. We performed a systematic review of GI-PTLD to better describe GI manifestations, risk factors for disease, and management of GI-PTLD. |
| Publish Date |
2022-08-18 06:01 |
| Citation |
Reiche W, Tauseef A, Sabri A, Mirza M, Cantu D, Silberstein P, Chandan S. Gastrointestinal manifestations, risk factors, and management in patients with post-transplant lymphoproliferative disorder: A systematic review. World J Transplant 2022; 12(8): 268-280 |
| URL |
https://www.wjgnet.com/2220-3230/full/v12/i8/268.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v12.i8.268 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
